Brain Injury Biomarkers in the General Population

Banyan Biomarkers, Inc5 sites in 1 country800 target enrollmentJanuary 2011

ConditionsBrain Injuries, Traumatic

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Brain Injuries, Traumatic
Sponsor: Banyan Biomarkers, Inc
Enrollment: 800
Locations: 5
Primary Endpoint: Assessment of the putative biomarkers for TBI markers in general population using an investigational assay
Status: Completed
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to use an investigational assay to assess levels of putative biomarkers of traumatic brain injury (TBI) in a general population. The data will be used in a correlative analysis with data collected under a separate study of severe TBI.

Registry

clinicaltrials.gov

Start Date

January 2011

End Date

September 2011

Last Updated

9 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Banyan Biomarkers, Inc

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•At least 18 years of age and no more than 80 years of age
•Willing to undergo consent
•PI believes volunteer is appropriate candidate for study

Exclusion Criteria

•Participating in another clinical study that may affect the results of either study
•Non-English speaking
•Venipuncture not feasible
•Blood donation within 1 week of screening
•PI determines volunteer is not medically suitable for study participation